A detailed history of Mig Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Mig Capital, LLC holds 10,872 shares of LLY stock, worth $11.1 Million. This represents 1.34% of its overall portfolio holdings.

Number of Shares
10,872
Previous 55,811 80.52%
Holding current value
$11.1 Million
Previous $43.5 Million 80.93%
% of portfolio
1.34%
Previous 4.85%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$625.65 - $812.69 $28.1 Million - $36.5 Million
-44,939 Reduced 80.52%
10,872 $8.3 Million
Q1 2025

May 14, 2025

SELL
$725.72 - $929.72 $7.35 Million - $9.41 Million
-10,125 Reduced 15.36%
55,811 $46.1 Million
Q4 2024

Feb 13, 2025

BUY
$727.2 - $932.06 $33 Million - $42.3 Million
45,355 Added 220.37%
65,936 $50.9 Million
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $15.9 Million - $19.8 Million
20,581 New
20,581 $18.2 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mig Capital, LLC Portfolio

Follow Mig Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mig Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mig Capital, LLC with notifications on news.